Venetoclax: How Does It Work?

Why hasn’t venetoclax (Venclexta) been approved as a front-line therapy for CLL? CLL experts, Dr. Nicole Lamanna and Dr. Michael Keating explain the mechanism behind venetoclax, offering insight into the behavior of this therapy and explaining the need for continued clinical trials.

Get email alerts | http://www.patientpower.info/alerts

Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo